meglumine has been researched along with Day Blindness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biousse, V; Bruce, BB; Newman, NJ; Riggeal, BD; Saindane, AM | 1 |
| Lundervold, A; Skalpe, IO; Tjørstad, K | 1 |
| Awwad, EE; Levy, E; Martin, DS; Merenda, GO | 1 |
1 trial(s) available for meglumine and Day Blindness
| Article | Year |
|---|---|
Complications of cerebral angiography. Comparing metrizamide (Amipaque) and meglumine metrizoate (Isopaque Cerebral).
Topics: Adolescent; Adult; Aged; Cerebral Angiography; Child; Child, Preschool; Double-Blind Method; Electrocardiography; Electroencephalography; Electromyography; Female; Hemiplegia; Humans; Infant; Infant, Newborn; Male; Meglumine; Metrizamide; Middle Aged; Sorbitol; Unconsciousness; Vision Disorders | 1980 |
2 other study(ies) available for meglumine and Day Blindness
| Article | Year |
|---|---|
Association of MRI findings and visual outcome in idiopathic intracranial hypertension.
Topics: Adolescent; Adult; Contrast Media; Female; Humans; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pseudotumor Cerebri; Spinal Puncture; Vision Disorders; Visual Field Tests | 2013 |
Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement.
Topics: Adult; Capillaries; Cerebellar Neoplasms; Cerebellum; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Ganglioneuroma; Humans; Hydrocephalus; Magnetic Resonance Imaging; Meglumine; Myelin Sheath; Neurons; Organometallic Compounds; Pentetic Acid; Vision Disorders | 1995 |